Member Info for MU345

Been here for months. But this is now starting to get some exposure. Once MHRA lands, government order. Then the media will do the work from there.

Sub £1 remains a bargain.

It’s fine, caps are ok...

WHILST WE ARE GOING BALLISTIC!

This is going to travel and travel fast.

Good work Safy.

I think we can all agree that it’s starting to look very promising.

‘Major exports’

‘Interest from all 5 continents’

MHRA and government order will take this to the same heights regardless of whether we are at 95p prior or 60p prior. You cannot tell me the value of this to the company is different between 1/2/3 weeks?

Just means when we go up we’ve got more ground to make up.

So when the update lands it should be starting in 3 figures as it would have if the update landed last week.

Did anyone manage to buy on that tree shake? I tried but couldn’t get anything..

Don’t think it matters where it goes because as shown by the previous price action a government order values this upwards of 3 figures easily.

“1/ INCREDIBLE STUDY:

615 adults in Tokyo were prospectively recruited to take Sars-Cov-2 antibody tests.

When the study began 6% had antibodies, indicating exposure.

By mid-summer 47% did. Half the population.

Not one person was hospitalized or died...”

https://www.medrxiv.org/content/10.1101/2020.09.21.20198796v1.full.pdf

Pfft. All I’ll say is. I hope the MM’s give this a good shake in the morning because I want a few more cheap before this heads North.

Not that I had any doubt previously (especially with the BBI leak). But with everything I’ve read up until now it’s clear that is now coming together very nicely.

We’ve challenged the mid 90’s twice, next time we break and we certainly don’t look back.

Old news, it is just reinforcing that this was always the plan.

“The consortium is working with NHSX – the technology, digital and data service of the NHS – to develop a test specific app and digital service that will facilitate use and reading of the test device. This will have the ability to integrate with NHS systems and update records.“ - https://businessnewswales.com/bbi-solutions-welcomes-uk-rapid-test-consortium-covid-19-progress/

Lots of good news coming through in the form of government guidance re antibody testing/ immunity. Now what seems to be the app for home antibody testing. I’ve never known so many ducks line up.

Share price is merely a buying opportunity at this point. I’ve got my sights set on an SP multiples of the current that’s for sure.

https://github.com/nhsx/antibody-web

“Covid-19 Antibody Test at Home Web Service is a wep based service that will allow registered users to take an at home Covid-19 Antibody test and get a result of whether they test positive or negative for Covid-19 antibodies.”

Exactly. Eventually 2,000,000 capacity per week.

The recently CE marked Mologic antibody test is said to provide a margin of circa £1.80. Whilst the RTC test sells for £13 but an exact margin to ODX is yet to be finalised. We await info on the antigen LFT’s.

But yep, precisely, WOW.

https://www.gov.uk/government/publications/national-covid-19-surveillance-reports/sero-surveillance-of-covid-19

“After making adjustments for the accuracy of the assay and the age and gender distribution of the population, the overall adjusted prevalence in London increased from 1.5% in week 13 to 12.3% in weeks 15 to 16 and 17.5% in week 18.”

Lots of guidance being updated with regard to antibodies over the past few days. My only worry a few months back was to what depth would the science support the case for antibody testing, and it’s looking to support it more than I ever thought it could.

I was under the impression that each member of the consortium had a role to play with either producing the test or distributing the test. I didn’t realise Abingdon Health was a one stop shop if you like. That just might need some ‘help’.

So you believe the only reason for the other companies in the consortium is to help with demand?

Ok, well BBI must be expecting that they can ‘help out’ too. As they’ve got numerous positions advertised all relating to the government RTC appose to work with the antigen LFT’s. https://bbigroup.peoplehr.net/Pages/JobBoard/Opening.aspx?v=7706bde9-1872-4972-b6ed-0ef9e0bab376

Motives change and so do opinions it seems.

Im sure I’ve read emails identifying significant demand for the ABC19 test. But it’s hardly a surprise.

Ive never been more confident here. The share price will try and change your opinion, but this could be sitting in 3 figures next week just like how it was above 90.00 5 days ago.

The closer we move towards the end of the year the greater the value. Full capacity amid commercial ramp up of the antigen LFT alongside the antibody tests... excellent.

Not sure it matters. MHRA approval, should gap back up to 95.00p at least, likely much more.

We re-tested the 52-week high with no RNS. Next time it will be broken and the rest will be history.

Very grateful for the opportunity to top up on this recent dip, because once MHRA approval lands this should comfortably in triple figures and that can land any day.

2,000,000 tests per week, lowest profit margin for the RTC test is £0.75 with it retailing at £13. This alongside CD4 and food intolerance would almost exceed current Mcap alone. Never mind tests selling at £1.80 and some likely much more.

Motley Fool even predicts profits at £128,000,000 which is lower than the current Mcap haha

Hence why come the end of the year I’m confident this will be trading around the 200p mark at least. So may the drop continue and I’ll continue hoovering up these golden tickets.